Hana B.
- Country
- Czechia
- Department
- NA
Research Overview
- Evaluation of the Efficacy and Safety of BI 690517 and Empagliflozin in Patients with Symptomatic Heart Failure and LVEF ≥40%: A Phase III Randomized Controlled Trial
- A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation
- Evaluation of Vicadrostat (BI 690517) and Empagliflozin Efficacy and Safety in Patients with Symptomatic Chronic Heart Failure and Reduced Ejection Fraction
Data & Insights
Has run more than one trial at 174 of 486 partner sites.
Specializations
Cardiovascular Disorders
This investigator specializes in treating complex cardiovascular conditions, with particular emphasis on heart failure and its various manifestations. Their research encompasses therapeutic approaches for patients with reduced left ventricular ejection fraction.
- Heart Failure Management
- Cardiovascular Death Prevention
- Hospital Admission Reduction
The investigator explores combination therapies involving novel pharmaceutical agents to improve outcomes in heart failure patients.
Cardiac Rhythm Disorders
The investigator focuses on managing atrial fibrillation and its associated complications. Their work includes evaluation of innovative anticoagulation strategies for preventing cardioembolic events.
- Stroke Prevention
- Systemic Embolism Management
- Anticoagulation Therapy
Their research involves assessment of novel anticoagulants for improved prevention of thromboembolic complications in atrial fibrillation patients.
Therapeutic Innovation
The investigator evaluates novel therapeutic compounds for cardiovascular conditions, particularly focusing on combination treatments and comparative effectiveness studies.
- Innovative Drug Development
- Combination Therapy Assessment
- Clinical Outcomes Research
Their work encompasses the evaluation of emerging cardiovascular medications and their potential benefits in various cardiac conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.